» Articles » PMID: 6334517

The Contribution of Ca2+ and Phospholipids to the Activation of Human Blood-coagulation Factor X by Activated Factor IX

Overview
Journal Biochem J
Specialty Biochemistry
Date 1984 Nov 1
PMID 6334517
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The role of the cofactors Ca2+ and phospholipid in the activation of human Factor X by Factor IXa was investigated. By use of a sensitive spectrophotometric Factor Xa assay, it was demonstrated that human Factor IXa can activate Factor X in the absence of cofactors. The presence of Ca2+ as the only cofactor resulted in a 7-fold stimulation of the Factor Xa formation. Kinetic analysis of the Ca2+-stimulated reaction showed that the apparent Km of Factor X was 4.6 microM, whereas the apparent Vmax. for Factor Xa formation was 0.0088 mol of Xa/min per mol of IXa. The presence of phospholipid as the only cofactor had no effect on the rate of Factor Xa formation. However, a several-hundred-fold stimulation was observed when Ca2+ and phospholipid were present in combination. The activation of Factor X in the presence of Ca2+ and phospholipid was found to be kinetically heterogeneous, involving both phospholipid-bound and free reactants. Quantitative data concerning the phospholipid binding of Factors IXa and X were used to study the relation between the rate of Factor Xa formation and the binding of enzyme and substrate to the phospholipid membrane. The results support the hypothesis that phospholipid-bound Factor X is the substrate in the phospholipid-stimulated reaction; however, phospholipid-bound and free Factor IXa seem to be equally efficient in catalysing the activation of phospholipid-bound Factor X.

Citing Articles

Impact of microparticles derived from erythrocytes on fibrinolysis.

Levin G, Sukhareva E, Lavrentieva A J Thromb Thrombolysis. 2015; 41(3):452-8.

PMID: 26590996 DOI: 10.1007/s11239-015-1299-y.


Microparticles in stored red blood cells: submicron clotting bombs?.

Rubin O, Crettaz D, Tissot J, Lion N Blood Transfus. 2010; 8 Suppl 3:s31-8.

PMID: 20606747 PMC: 2897194. DOI: 10.2450/2010.006S.


Heparin modulates the 99-loop of factor IXa: effects on reactivity with isolated Kunitz-type inhibitor domains.

Neuenschwander P, Williamson S, Nalian A, Baker-Deadmond K J Biol Chem. 2006; 281(32):23066-74.

PMID: 16766524 PMC: 1839010. DOI: 10.1074/jbc.M603743200.


An ordered sequential mechanism for Factor IX and Factor IXa binding to platelet receptors in the assembly of the Factor X-activating complex.

Yang X, Walsh P Biochem J. 2005; 390(Pt 1):157-67.

PMID: 15755260 PMC: 1184571. DOI: 10.1042/BJ20050029.


Surface-loop residue Lys316 in blood coagulation Factor IX is a major determinant for Factor X but not antithrombin recognition.

Kolkman J, Mertens K Biochem J. 2000; 350 Pt 3:701-7.

PMID: 10970782 PMC: 1221300.


References
1.
Griffith M, Reisner H, Lundblad R, Roberts H . Measurement of human factor IXa activity in an isolated factor X activation system. Thromb Res. 1982; 27(3):289-301. DOI: 10.1016/0049-3848(82)90076-7. View

2.
Osterud B, RAPAPORT S . Synthesis of intrinsic factor X activator. Inhibition of the function of formed activator by antibodies to factor VIII and to factor IX. Biochemistry. 1970; 9(8):1854-61. DOI: 10.1021/bi00810a028. View

3.
Dombrose F, Gitel S, Zawalich K, Jackson C . The association of bovine prothrombin fragment 1 with phospholipid. Quantitative characterization of the Ca2+ ion-mediated binding of prothrombin fragment 1 to phospholipid vesicles and a molecular model for its association with phospholipids. J Biol Chem. 1979; 254(12):5027-40. View

4.
Mertens K, Bertina R . Pathways in the activation of human coagulation factor X. Biochem J. 1980; 185(3):647-58. PMC: 1161442. DOI: 10.1042/bj1850647. View

5.
Hemker H, Kahn M . Reaction sequence of blood coagulation. Nature. 1967; 215(5106):1201-2. DOI: 10.1038/2151201a0. View